- DESCRIPTION
- TABLE OF CONTENTS
- METHODOLOGY
- DOWNLOAD PDF
Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, Workcell, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, HTS), End User (Pharma, Forensic, Environmental, Diagnostic Lab) - Global Forecast to 2031
USD 8.62 BN
MARKET SIZE, 2031
LAB AUTOMATION MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global lab automation market is projected to grow from USD 6.60 billion in 2026 to USD 8.62 billion by 2031, at a CAGR of 6.6% during the forecast period. The market was valued at USD 6.26 billion in 2025. The primary driver for growth in the lab automation market is the increasing demand for high-throughput screening, which enables laboratories to process large volumes of samples more efficiently in drug discovery and diagnostics. Automated systems reduce human intervention, resulting in accurate outcomes for both clinical and research applications. Additionally, a shortage of skilled workers amplifies the need for solutions that require minimal supervision, thereby reducing labor costs and enhancing efficiency. Ongoing developments in robotics, artificial intelligence, and machine learning further enhance automation capabilities. Other contributing factors to the market's growth include the personalization of medicine, rising investments in research and development, regulatory compliance, and cost-effectiveness.
KEY TAKEAWAYS
-
BY REGION
By region, the Asia Pacific is projected to witness the highest CAGR during the forecast period.
-
BY PRODUCT
By product, the automated workstations segment accounted for the largest market share of 40.2% in 2025.
-
BY APPLICATION
By application, the drug discovery segment accounted for 39.0% of the lab automation market in 2025.
-
BY END USER
By end user, the hospitals & diagnostic laboratories segment accounted for the largest share in 2025.
-
COMPETITIVE LANDSCAPE - KEY PLAYERS
Thermo Fisher Scientific Inc. (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are identified as some of the star players in the lab automation market, given their strong global market presence, extensive portfolios, advanced R&D capabilities, and well-established distribution networks across developed and emerging regions.
-
COMPETITIVE LANDSCAPE - OTHER PLAYERS
These companies offer unique products that have started occupying a niche for themselves within the industry. Their business and product superiority is yet to be matched when compared to some other leading start-up firms. Some of the most successful firms in this segment include: Universal Robots (Denmark), AB Controls, Inc. (US), and BMG Labtech (Germany).
The growing demand for high-throughput screening is the main driving force behind the lab automation market. This demand allows laboratories to process large volumes of samples more efficiently in drug discovery and diagnostics. Automated systems minimize human intervention, leading to fewer errors and more accurate results for both clinical and research applications. Additionally, a shortage of skilled personnel increases the need for solutions that require minimal supervision, helping to reduce labor costs while enhancing efficiency. Advances in robotics, artificial intelligence, and machine learning further enhance automation capabilities. Other factors contributing to the growth of this market include the personalization of medicine, increased investment in research and development, regulatory compliance, and cost-effectiveness.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
Several trends and innovations are transforming the lab automation sector. Firstly, there is a rising trend towards automating and integrating laboratory processes to optimize all aspects of sample preparation and analysis. Laboratories are gradually incorporating robotic equipment, automation modules, and advanced liquid handling systems to improve efficiency and reduce errors associated with manual operations. Additionally, the adoption of artificial intelligence and laboratory information management systems is becoming more common to enhance performance. Lastly, the increasing demand for speed, cost-effectiveness, and standardization in labs is driving the widespread adoption of lab automation.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
OPPORTUNITIES
Impact
Level
-
Increased expenditure on healthcare
-
Growth in pharmaceutical and biotechnology industries
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Lab automation plays a crucial role in drug discovery by simplifying complex tasks, improving accuracy, and enhancing speed. High-throughput screening can be automated, allowing thousands of compounds to be evaluated much more quickly, which accelerates the identification of potential drug candidates. Additionally, automation helps manage large data sets and streamlines workflows, leading to faster drug development. However, target identification and regulatory compliance processes remain bottlenecks in earlier stages of development. The use of 3D cell models helps to reduce variability and improve safety. In organ-on-chip cultures, microfluidics technology is essential. Together, these advancements represent significant steps toward developing more efficient and reliable automation solutions for drug discovery in the future.
Major factors limiting the developing world from fully utilizing lab automation technologies include financial constraints. The costs associated with repairing and servicing laboratory informatics systems are often significantly higher than the initial software acquisition price. Experts indicate that, in most cases, maintaining IT systems can incur recurring costs amounting to 20–30% of the total cost of ownership due to upgrades and other maintenance activities as needs change over time. Additionally, training and implementing this technology can add as much as 15% to the overall cost. This presents a substantial financial burden for small to medium-sized laboratories. Furthermore, the cost-effectiveness of automated systems has yet to be clearly established. The lack of information contributes to risk aversion among potential adopters, who may hesitate to make large investments without concrete evidence of returns on investment. The long-term cost-effectiveness of automation in lab settings is not well-documented, which is why the slow introduction of automation in developing markets delays the realization of its associated benefits, such as improved efficiency and productivity.
Most research and development (R&D) in medicine worldwide is conducted by firms based in the US, which also hold the patents for the majority of medicines discovered globally. The biopharmaceutical industry has produced over 5,000 medicines around the world, with approximately 3,400 compounds currently in clinical trials in the US, more than any other country. Emerging players in this field include India and China, both of which are developing their respective pharmaceutical and biotechnology sectors. The Indian pharmaceutical industry fulfills more than half of the global demand for various vaccines and provides 40% of the generic medicines consumed in America. Additionally, the Chinese government has made significant efforts to accelerate the development of pharmaceuticals and biotechnology. Biotechnology is highlighted as a key industry in both the 13th Five-Year Plan and the Made in China 2025 initiative.
The primary challenge in lab automation lies in system integration. This difficulty mainly stems from the integration issues associated with disparate technologies and legacy systems, which are often not compatible with modern automated configurations. When new technologies are introduced into an existing laboratory setup, problems arise due to poor communication between older hardware and software platforms and advanced automation tools. Laboratories typically have numerous instruments and data management systems, all of which are proprietary and operate under unique protocols and formats. This leads to ongoing issues with interoperability. Non-seamless integration can result in delays, inaccurate data, and costly customizations needed to make different systems work together. As a result, the potential benefits of automation—such as increased efficiency, accuracy, and throughput—are frequently diminished. The integration process is followed by calibration, validation, and potential downtime, which can further extend the implementation timeline and costs, especially if specialized expertise is required. Strategic planning, often in the form of customized solutions, is essential to maintain a lab automation system that is integrated, efficient, and compliant. Additionally, training for personnel is necessary to successfully incorporate automation solutions into existing devices.
LAB AUTOMATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Provides a wide range of laboratory automation products, such as robotic equipment, automated liquid dispensers, incubators, and other workflow automation instruments for research and diagnostic laboratories. | Assures high-throughput capacity, accuracy, minimal manual errors, and scalability of laboratory operations. |
|
|
Delivers robotic liquid handlers, automation modules, and detection devices that are extensively used in genomics, drug development, and diagnostic testing. | Improves accuracy, reproducibility, and adaptability of laboratory processes. |
|
|
Provides complete solutions for laboratory automation, sample preparation automation, and bioprocessing automation within its life sciences and diagnostics product line. | Provides quick turnaround, efficiency, and minimizes manual labor in laboratories. |
|
|
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
Market participants in lab automation encompass a variety of roles, including vendors of automation equipment and software, suppliers of components and consumables, system integrators, distributors, and end users such as pharmaceutical and biotech companies, hospitals, and research laboratories. The focus within the lab automation market is on developing innovative solutions that enhance the processing and handling of samples, as well as information management. Notable companies in this market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Agilent Technologies (US), Tecan Group (Switzerland), and F. Hoffmann-La Roche Ltd. (Switzerland).
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
It is predicted that automated workstations will dominate the global laboratory automation market by 2025, primarily due to their role in enhancing the efficiency and accuracy of laboratory processes. These workstations are designed to fully automate sample preparation, data analysis, and liquid handling. They are particularly relevant in industries such as pharmaceuticals, biotechnology, and clinical diagnostics. The rising demand for high-throughput and error-free workflows in areas like drug discovery and genomics has increased the need for these workstations, as they reduce manual labor through automation. Consequently, leading companies are utilizing them extensively. For example, the Fluent Liquid Handler from Tecan Group (Switzerland) improves liquid handling speed and precision, featuring one or three robotic arms capable of performing pipetting, tip ejection, and gripping functions. Moreover, the integration of robotics and software advancements in laboratories has further enhanced the functionality of these workstations. This progress helps laboratories comply with regulatory requirements while optimizing complex testing workflows.
In 2025, the hospitals & diagnostic laboratory segment held the largest market share. This was driven by the growing demand for high-throughput and efficient solutions needed to manage large volumes of samples and the increasing complexity of testing. Automation plays a crucial role in improving workflow efficiency and reducing human errors, enabling instant and accurate diagnostic results. This transformation not only enhances patient care outcomes but also highlights the significant impact of automation. Technologies such as sample handling systems and data management platforms enable laboratories to conduct a large number of tests with improved accuracy, thereby supporting better patient care.
In 2025, drug discovery emerged as the leading application segment in the lab automation market, driven by the pharmaceutical industry's need for efficient, high-throughput screening solutions. Automation has significantly minimized manual labor during crucial stages of drug discovery, including compound screening, lead optimization, and assay development. This has led to accelerated workflows and enhanced precision. Achieving a high throughput of sample volumes with accuracy and consistency is essential for the rapid identification of viable drug candidates at a reasonable cost. Key industry players are successfully utilizing automation technology for drug discovery. For example, the LINQ platform from Automata (UK) supports drug discovery processes such as assays and tissue culture, further contributing to the growth of this segment in the lab automation market.
REGION
US to account for largest share of North American lab automation market during forecast period
In North America, the lab automation market will be primarily dominated by the US during the forecast period. This is largely attributed to several key factors, including the significant presence of pharmaceutical and biotechnology companies in the region. In January 2025, Agilent Technologies (US) announced an investment of USD 725 million to expand its capacity for producing therapeutic nucleic acids. Additionally, the growing demand for more efficient laboratory operations—particularly in managing increased volumes of diagnostic tests and drug development—is driving market growth. Supportive initiatives from the US government aimed at promoting healthcare innovation and the adoption of advanced technologies have also facilitated the greater use of automated systems, which in turn enhances productivity and accuracy. Furthermore, the smooth integration of new technologies, such as artificial intelligence and robotics, has bolstered the position of the US lab automation market. As a result, the US is expected to remain the leading nation in this sector in the future, achieving greater operational efficiency and shorter turnaround times.
LAB AUTOMATION MARKET: COMPANY EVALUATION MATRIX
Some key players in the lab automation market include Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies, Tecan Group, and F. Hoffmann-La Roche Ltd. These companies have established prominence due to their strong market leadership, diverse product portfolios, significant investments in research and development, and extensive global distribution networks. In addition to these well-known organizations, there are several emerging companies making their mark in the industry, such as LabVantage Solutions, SPT Labtech, Automata, Aurora Biomed Inc., and BMG Labtech. These new entrants are gaining popularity by offering specialized products, innovative solutions, and cost-effective offerings. Although they may not have the same level of recognition as the leading companies, they are able to compete effectively by leveraging unique technologies and solutions.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Thermo Fisher Scientific (US)
- Tecan Group (Switzerland)
- Danaher Corporation (US)
- Agilent Technologies (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Revvity (US)
- Eppendorf AG (Germany)
- Becton, Dickinson and Company (US)
- Waters Corporation (US)
- Siemens Healthineers (Germany)
- Abbott Laboratories (US)
- bioMérieux (France)
- Hamilton Company (US)
- Hudson Robotics (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 6.26 Billion |
| Market Forecast in 2031 (Value) | USD 8.62 Billion |
| Growth Rate | CAGR of 6.6% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East & Africa |
WHAT IS IN IT FOR YOU: LAB AUTOMATION MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Lab Automation System Manufacturer |
|
|
| Healthcare Provider/Diagnostic Laboratory |
|
|
RECENT DEVELOPMENTS
- July 2025 : Tecan Group (Switzerland) collaborated with Singular Genomics Systems, Inc. (US) to design customized reagent kits for the NGS library preparation system in a bid to streamline efficiency and workflow optimization in genomics research.
- February 2025 : Tecan (Switzerland) collaborated with Element Biosciences, Inc. (US) by combining Tecan's automation solutions with the advanced sequencing techniques offered by Element.
- December 2023 : Danaher Corporation (US) acquired Abcam plc (UK) to mark its presence in the proteomics sector. The deal size was USD 5.60 billion.
- April 2022 : Revvity, Inc. (US) collaborated with Scitera Corporation (US) to create a new lab model that advances lab automation by improved management of data and collaboration of scientists from multiple disciplines.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
4
MARKET OVERVIEW
46
4.2.1.1
NEED FOR AUTOMATION IN DRUG DISCOVERY
4.2.1.2
ADVANCEMENTS IN ARTIFICIAL INTELLIGENCE AND ROBOTICS
4.2.1.3
GROWTH IN DEMAND FOR PROCESS AUTOMATION FOR FOOD SAFETY
4.2.1.4
RISE IN DEMAND FOR AUTOMATION IN FORENSICS
4.2.2.1
HIGH INITIAL INVESTMENT COSTS
4.2.2.2
SLOW ADOPTION IN DEVELOPING REGIONS
4.2.3.1
INCREASED EXPENDITURE ON HEALTHCARE
4.2.3.2
GROWTH IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES
4.2.4.1
SYSTEM INTEGRATION ISSUES
4.2.4.2
AVAILABILITY OF REFURBISHED LAB AUTOMATION EQUIPMENT
4.3
UNMET NEEDS AND WHITE SPACES
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
54
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF SUPPLIERS
5.1.4
BARGAINING POWER OF BUYERS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC OUTLOOK
5.2.2
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
5.2.3
MACROECONOMIC OUTLOOK FOR EUROPE
5.2.4
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
5.2.5
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
5.2.6
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
5.2.7
TRENDS IN GLOBAL LIQUID HANDLING SYSTEM MARKET
5.2.8
TRENDS IN GLOBAL MICROPLATE SYSTEM MARKET
5.3.1
RESEARCH & DEVELOPMENT
5.3.2
RAW MATERIAL PROCUREMENT & MANUFACTURING
5.3.3
DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
5.5.1
AVERAGE SELLING PRICE TREND, BY REGION
5.5.2
AVERAGE SELLING PRICE OF ROBOTIC ARMS, BY KEY PLAYER
5.6.1
IMPORT DATA (HS CODE 8479)
5.6.2
EXPORT DATA (HS CODE 8479)
5.7
KEY CONFERENCES & EVENTS, 2026–2027
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.10.1
TOTAL LABORATORY AUTOMATION FOR ENHANCED WORKFORCE PRODUCTIVITY IN CLINICAL CHEMISTRY AND SEROLOGY
5.10.2
PRE-ANALYTICAL AUTOMATION AND LIMS INTEGRATION FOR LABORATORY DIGITAL TRANSFORMATION IN PHARMACEUTICAL MANUFACTURING
5.10.3
TOTAL LAB AUTOMATION AND LEAN PRINCIPLES FOR MICROBIOLOGY WORKFLOW OPTIMIZATION
5.11
IMPACT OF US TARIFFS
5.11.3
PRICE IMPACT ANALYSIS
5.11.4
IMPACT ON COUNTRIES/REGIONS
5.11.5
IMPACT ON END-USERS
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACTS, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
74
6.1.3
HIGH-THROUGHPUT SCREENING (HTS) TECHNOLOGIES
6.1.4
COMPLEMENTARY TECHNOLOGY
6.1.4.1
CLOUD CONNECTIVITY
6.1.4.2
INTERNET OF THINGS (IOT)
6.1.5
ADJACENT TECHNOLOGY
6.1.5.1
MICROFLUIDICS TECHNOLOGY
6.4
IMPACT OF AI/GEN AI ON LAB AUTOMATION MARKET
6.4.1
TOP USE CASES AND MARKET POTENTIAL
6.4.2
BEST PRACTICES FOLLOWED BY COMPANIES
6.4.3
CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION
6.4.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.4.5
CLIENTS' READINESS TO ADOPT AI/GEN AI IN LAB AUTOMATION MARKET
6.5
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7
REGIONAL REGULATIONS AND COMPLIANCE
84
7.1.1
REGULATORY STANDARDS AND APPROVALS
7.1.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
7.2.1
DECISION-MAKING PROCESS
7.3
KEY STAKEHOLDERS IN BUYING PROCESS AND EVALUATION CRITERIA
7.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
7.3.2
KEY BUYING CRITERIA
7.4
ADOPTION BARRIERS AND INTERNAL CHALLENGES
7.5
UNMET NEEDS OF VARIOUS APPLICATIONS
8
LAB AUTOMATION MARKET, BY APPLICATION
93
8.2.1
ACCELERATION OF DRUG DEVELOPMENT TIMELINE TO DRIVE MARKET
8.2.2
HIGH-THROUGHPUT SCREENING
8.2.2.1
INTEGRATION WITH AUTOMATION TECHNOLOGIES HELPS RAPIDLY IDENTIFY COMPOUNDS
8.2.3
COMPOUND MANAGEMENT
8.2.3.1
OFFERINGS BY PROMINENT PLAYERS SUPPORT GROWTH
8.2.4.1
GROWING REQUIREMENT FOR ADME SCREENING IN DRUG DISCOVERY TO FUEL SEGMENT
8.2.5
COMPOUND WEIGHING & DISSOLUTION
8.2.5.1
POTENTIAL TO IMPROVE PRECISION AND OPERATIONAL EFFICIENCY WITHOUT USER INTERVENTION TO BOOST GROWTH
8.2.6
OTHER DRUG DISCOVERY APPLICATIONS
8.3.1
NEED FOR AUTOMATED INSTRUMENTS FOR PRECISION AND EFFICIENCY IN DIAGNOSTICS
8.3.2
PRE-ANALYTICS/SAMPLE PREPARATION
8.3.2.1
AUTOMATION MINIMIZES ERRORS AND CUTS LABOR COSTS WHILE ENHANCING PRECISION AND PRODUCTIVITY
8.3.3
ENZYME IMMUNOASSAYS
8.3.3.1
RISING DEMAND FOR AUTOMATION OF EIA PROCESSES
8.3.4
SAMPLE DISTRIBUTION, SPLITTING, AND ARCHIVING
8.3.4.1
EASE OF MONITORING INTERACTION AND NEED FOR REDUCED TUBE MANIPULATION TO DRIVE SEGMENT
8.4.1
INCREASING APPLICATION OF AUTOMATION IN GENOMICS TO FUEL GROWTH
8.5.1
DEMAND FOR ROBOTICS TO REDUCE COMPLEXITY OF PROTEOME DATASETS
8.6.1
INCREASING PRECISION AND EFFICIENCY SUPPORT DEMAND
9
LAB AUTOMATION MARKET, BY PRODUCT
110
9.2
AUTOMATED WORKSTATIONS
9.2.1
AUTOMATED LIQUID HANDLING SYSTEMS
9.2.1.1
AUTOMATED INTEGRATED WORKSTATIONS
9.2.1.1.1
INCREASE IN APPLICATIONS OF WORKSTATIONS
9.2.1.2
PIPETTING SYSTEMS
9.2.1.2.1
APPLICATION OF AUTOMATED PIPETTING SYSTEMS ACROSS DIFFERENT SECTORS
9.2.1.3
REAGENT DISPENSERS
9.2.1.3.1
ADOPTION OF ADVANCED TECHNOLOGIES BY PROMINENT PLAYERS
9.2.1.4
MICROPLATE WASHERS
9.2.1.4.1
MULTIPLE BENEFITS PROVIDED BY MICROPLATE WASHERS
9.2.2.1
MULTI-MODE MICROPLATE READERS
9.2.2.1.1
FILTER-BASED READERS
9.2.2.1.2
MONOCHROMATOR-BASED READERS
9.2.2.2
SINGLE-MODE MICROPLATE READERS
9.2.2.2.1
FLUORESCENCE READERS
9.2.2.2.2
ABSORBANCE READERS
9.2.2.2.3
LUMINESCENCE READERS
9.2.3
AUTOMATED ELISA SYSTEMS
9.2.3.1
INTEGRATION OF AUTOMATION INTO ELISA SYSTEM OFFERS MORE BENEFITS
9.2.4
AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS
9.2.4.1
WIDE APPLICATIONS OF AUTOMATED NUCLEIC ACID EXTRACTION SYSTEMS
9.3
OFF-THE-SHELF AUTOMATED WORK CELLS
9.3.1
PRE-ANALYTICAL AUTOMATION
9.3.1.1
ENHANCED EFFICIENCY THROUGH PRE-ANALYTICAL AUTOMATION SYSTEM
9.3.2
POST-ANALYTICAL AUTOMATION
9.3.2.1
INNOVATIVE AUTOMATED PRODUCT LAUNCHES
9.3.3
TOTAL LAB AUTOMATION
9.3.3.1
DESPITE ITS ADVANTAGES, TOTAL AUTOMATION CHALLENGING TO IMPLEMENT IN MOST LABS
9.4.1
LABORATORY INFORMATION MANAGEMENT SYSTEMS
9.4.1.1
MINIMIZING HUMAN ERRORS AND INCREASING EFFICACY
9.4.2
ELECTRONIC LABORATORY NOTEBOOKS
9.4.2.1
DATA SECURITY AND USER-FRIENDLY INTERFACE OF ELN
9.4.3
LABORATORY EXECUTION SYSTEMS
9.4.3.1
LES PROVIDES PAPERLESS, HIGH-PRODUCTIVITY ENVIRONMENT
9.4.4
SCIENTIFIC DATA MANAGEMENT SYSTEMS
9.4.4.1
INCREASED APPLICATION OF SDMS IN RESEARCH
9.5.1.1
FLEXIBILITY, ACCURACY, AND ENHANCED TO INCREASE APPLICATION OF ROBOTIC ARMS
9.5.2.1
INNOVATIVE PRODUCTS OFFERED BY KEY PLAYERS
9.5.3
COLLABORATIVE ROBOTS
9.5.3.1
RAPIDLY EXPANDING ROBOTICS TECHNOLOGY WITH SIGNIFICANT MARKET POTENTIAL
9.5.4.1
SIGNIFICANT TECHNOLOGICAL TRENDS AND INTEGRATION WITH SOFTWARE
9.6
AUTOMATED STORAGE & RETRIEVAL SYSTEMS
9.6.1
AUTOMATED STORAGE AND RETRIEVAL SYSTEMS PLAY AN IMPORTANT ROLE IN DRUG DISCOVERY
9.7
OTHER LAB AUTOMATION EQUIPMENT
10
LAB AUTOMATION MARKET, BY END USER
168
10.2
BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
10.2.1
NEED FOR ACCURACY DRIVES DEMAND FOR AUTOMATION
10.3
HOSPITAL & DIAGNOSTIC LABORATORIES
10.3.1
AUTOMATION MEETS DEMAND FOR FAST AND PRECISE RESULTS
10.4
RESEARCH & ACADEMIC INSTITUTES
10.4.1
INCREASE IN BIOTECHNOLOGY AND LIFE SCIENCE RESEARCH
10.5
ENVIRONMENTAL TESTING LABORATORIES
10.5.1
INTEGRATING AUTOMATION IN ENVIRONMENTAL TESTING LABS TO ENHANCE EFFICIENCY
10.6
FORENSIC LABORATORIES
10.6.1
PROMINENT COMPANIES TO ADOPT AUTOMATION IN FORENSICS FOR BETTER OUTCOME
10.7
FOOD & BEVERAGE INDUSTRY
10.7.1
INCREASING UTILIZATION OF ROBOTIC ARMS IN FOOD & BEVERAGE INDUSTRY
11
LAB AUTOMATION MARKET, BY REGION
177
11.2.1.1
STRATEGIES ADOPTED BY PROMINENT PLAYERS
11.2.2.1
INNOVATIVE PRODUCTS RELATED TO AUTOMATION TO BOOST GROWTH
11.3.1.1
PRESENCE OF PUBLIC & PRIVATE ORGANIZATIONS
11.3.2.1
RISING EXPENDITURE BY PHARMA AND BIOTECH COMPANIES
11.3.3.1
ADVANCED AUTOMATED SOLUTIONS
11.3.4.1
EXPANSION OF TOTAL LABORATORY AUTOMATION IN CLINICAL DIAGNOSTICS
11.3.5.1
RECENT DEVELOPMENTS IN AUTOMATION TO PROPEL GROWTH
11.3.6.1
NETHERLANDS LEADS IN R&D FOR LAB AUTOMATION SOLUTIONS
11.4.1.1
ADVANCED AUTOMATION SOLUTIONS BROUGHT BY KEY PLAYERS
11.4.2.1
STRATEGIC PARTNERSHIPS AND EXPANSIONS
11.4.3.1
AUTOMATION TECHNOLOGY GAINING TRACTION IN INDIAN CLINICS AND HOSPITALS
11.4.4.1
ADVANCEMENTS IN LABORATORY AUTOMATION AND ANALYTICAL WORKFLOWS
11.4.5.1
RISING INVESTMENTS IN AI-DRIVEN AND AUTOMATED LABORATORY INFRASTRUCTURE
11.4.6
REST OF ASIA PACIFIC
11.5.1.1
INCREASED EXPENDITURE AND EXPANSIONS
11.5.2.1
FAVORABLE BUSINESS ENVIRONMENT FOR MARKET PLAYERS
11.5.3
REST OF LATIN AMERICA
11.6
MIDDLE EAST & AFRICA
11.6.1
MIDDLE EAST & AFRICA TO ACCOUNT FOR SMALLEST SHARE OF GLOBAL MARKET
11.6.2.1
GROWING ADOPTION OF AI-ENABLED AND AUTOMATED LABORATORY INFRASTRUCTURE
11.6.3
REST OF MIDDLE EAST & AFRICA
12
COMPETITIVE LANDSCAPE
275
12.2
KEY PLAYER STRATEGY/RIGHT TO WIN
12.3
REVENUE ANALYSIS, 2021–2025
12.4
MARKET SHARE ANALYSIS, 2023
12.4.1
RANKING OF KEY MARKET PLAYERS
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.5.5.1
COMPANY FOOTPRINT
12.5.5.2
REGIONAL FOOTPRINT
12.5.5.3
APPLICATION FOOTPRINT
12.5.5.4
END USER FOOTPRINT
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.6.1
PROGRESSIVE COMPANIES
12.6.2
RESPONSIVE COMPANIES
12.6.5
COMPANY BENCHMARKING: STARTUPS/SMES, 2024
12.6.5.1
COMPETITIVE BENCHMARKING OF EMERGING PLAYERS/STARTUPS
12.6.5.2
DETAILED LIST OF KEY STARTUPS/SMES
12.7
COMPANY VALUATION AND FINANCIAL METRICS
12.8
PRODUCT/BRAND COMPARISON
12.9
COMPETITIVE SCENARIO
12.9.1
PRODUCT LAUNCHES AND APPROVALS
13
COMPANY PROFILES
295
13.1.1
THERMO FISHER SCIENTIFIC INC.
13.1.1.1
BUSINESS OVERVIEW
13.1.1.2
PRODUCTS OFFERED
13.1.1.3
RECENT DEVELOPMENTS
13.1.1.3.1
PRODUCT LAUNCHES AND APPROVALS
13.1.1.4.2
STRATEGIC CHOICES
13.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
13.1.3
DANAHER CORPORATION
13.1.4
AGILENT TECHNOLOGIES
13.1.5
F. HOFFMANN-LA ROCHE LTD.
13.1.9
BECTON, DICKINSON AND COMPANY
13.1.10
WATERS CORPORATION
13.1.11
SIEMENS HEALTHINEERS
13.1.12
ABBOTT LABORATORIES
13.1.15
HUDSON LAB AUTOMATION
13.2.4
AURORA BIOMED INC.
13.2.5
HIGHRES BIOSOLUTIONS
13.2.6
OPENTRONS LABWORKS INC.
13.2.7
PEAK ANALYSIS AND AUTOMATION
13.2.9
LABVANTAGE SOLUTIONS, INC.
13.2.10
BIO-RAD LABORATORIES, INC.
13.2.12
SYSMEX CORPORATION
13.2.14
AB CONTROLS, INC.
14
RESEARCH METHODOLOGY
375
14.2.1
SECONDARY RESEARCH
14.2.1.1
KEY DATA FROM SECONDARY SOURCES
14.2.2.2
KEY INDUSTRY INSIGHTS
14.3
MARKET SIZE ESTIMATION
14.3.1
BOTTOM-UP APPROACH
14.3.1.1
APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
14.3.1.2
APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
14.3.1.3
APPROACH 3: TOP-DOWN APPROACH
14.3.1.4
APPROACH 4: PRIMARY INTERVIEWS
14.6
MARKET SHARE ASSESSMENT
14.7
RESEARCH ASSUMPTIONS
14.8
RESEARCH LIMITATIONS
15.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3
CUSTOMIZATION OPTIONS
TABLE 1
LAB AUTOMATION MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2
COMPANIES AND THEIR LAB AUTOMATION TECHNOLOGIES FOR DRUG DISCOVERY
TABLE 3
LAB AUTOMATION MARKET: UNMET NEEDS
TABLE 4
STRATEGIC FOCUS OF TIER-1/2/3 PLAYERS
TABLE 5
LAB AUTOMATION MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 6
NORTH AMERICA: MACROECONOMIC OUTLOOK
TABLE 7
EUROPE: MACROECONOMIC OUTLOOK
TABLE 8
ASIA PACIFIC: MACROECONOMIC OUTLOOK
TABLE 9
LATIN AMERICA: MACROECONOMIC OUTLOOK
TABLE 10
MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
TABLE 11
LAB AUTOMATION MARKET: ROLE OF ECOSYSTEM
TABLE 12
AVERAGE SELLING PRICE OF LAB AUTOMATION EQUIPMENT, BY REGION, 2023–2025 (USD THOUSAND)
TABLE 13
AVERAGE SELLING PRICE OF ROBOTIC ARMS, BY KEY PLAYER, 2025 (USD THOUSAND)
TABLE 14
IMPORT DATA FOR HS CODE 8479, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 15
EXPORT DATA FOR HS CODE HS CODE 8479, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 16
LIST OF KEY CONFERENCES AND EVENTS, 2026–2027
TABLE 17
US-ADJUSTED RECIPROCAL TARIFF RATES IN MEDTECH INDUSTRY
TABLE 18
THE TARIFF-INDUCED PRICE INCREASES FOR HEALTHCARE PRODUCTS
TABLE 19
INNOVATIONS AND PATENT REGISTRATIONS, 2022–2026
TABLE 20
KEY COMPANIES IMPLEMENTING AI/GEN AI
TABLE 21
KEY APPLICATIONS AND CLINICAL OUTCOMES
TABLE 22
US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 23
CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
TABLE 24
EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
TABLE 25
JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION
TABLE 26
CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION
TABLE 27
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 29
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 30
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 31
ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 32
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
TABLE 33
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER
TABLE 34
LAB AUTOMATION MARKET: UNMET NEED ANALYSIS
TABLE 35
LAB AUTOMATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 36
LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2023–2030 (USD MILLION)
TABLE 37
LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY REGION, 2023–2030 (USD MILLION)
TABLE 38
LAB AUTOMATION MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2023–2030 (USD MILLION)
TABLE 39
LAB AUTOMATION MARKET FOR COMPOUND MANAGEMENT, BY REGION, 2023–2030 (USD MILLION)
TABLE 40
LAB AUTOMATION MARKET FOR ADME SCREENING, BY REGION, 2023–2030 (USD MILLION)
TABLE 41
LAB AUTOMATION MARKET FOR COMPOUND WEIGHING & DISSOLUTION, BY REGION, 2023–2030 (USD MILLION)
TABLE 42
LAB AUTOMATION MARKET FOR OTHER DRUG DISCOVERY APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 43
LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 44
LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 45
LAB AUTOMATION MARKET FOR PRE-ANALYTICS/SAMPLE PREPARATION, BY REGION, 2023–2030 (USD MILLION)
TABLE 46
LAB AUTOMATION MARKET FOR ENZYME IMMUNOASSAYS, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
LAB AUTOMATION MARKET FOR SAMPLE DISTRIBUTION, SPLITTING, AND ARCHIVING, BY REGION, 2023–2030 (USD MILLION)
TABLE 48
LAB AUTOMATION MARKET FOR GENOMICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 49
LAB AUTOMATION MARKET FOR PROTEOMICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 50
LAB AUTOMATION MARKET FOR MICROBIOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 51
LAB AUTOMATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
TABLE 52
LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 53
LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (UNITS)
TABLE 54
AUTOMATED WORKSTATIONS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 55
AUTOMATED WORKSTATIONS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 56
AUTOMATED WORKSTATIONS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 57
AUTOMATED WORKSTATIONS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 58
AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 59
AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 60
LAB AUTOMATION MARKET FOR AUTOMATED LIQUID HANDLING SYSTEMS, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 61
LAB AUTOMATION MARKET FOR AUTOMATED LIQUID HANDLING SYSTEMS, BY END USER, 2023–2030 (USD MILLION)
TABLE 62
AUTOMATED INTEGRATED WORKSTATIONS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 63
AUTOMATED PIPETTING SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 64
AUTOMATED REAGENT DISPENSERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 65
AUTOMATED MICROPLATE WASHERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 66
AUTOMATED MICROPLATE READERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 67
AUTOMATED MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 68
AUTOMATED MICROPLATE READERS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 69
AUTOMATED MICROPLATE READERS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 70
AUTOMATED MULTI-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 71
AUTOMATED MULTI-MODE MICROPLATE READERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 72
AUTOMATED FILTER-BASED READERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 73
AUTOMATED MONOCHROMATOR-BASED READERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 74
AUTOMATED HYBRID READERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 75
AUTOMATED SINGLE-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 76
AUTOMATED SINGLE-MODE MICROPLATE READERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 77
AUTOMATED FLUORESCENCE READERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 78
AUTOMATED ABSORBANCE READERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 79
AUTOMATED LUMINESCENCE READERS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 80
AUTOMATED ELISA SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 81
AUTOMATED ELISA SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 82
AUTOMATED ELISA SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 83
AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 84
AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 85
AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 86
OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 87
OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 88
OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 89
OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 90
PRE-ANALYTICAL AUTOMATION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 91
PRE-ANALYTICAL AUTOMATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 92
LAB AUTOMATION MARKET FOR PRE-ANALYTICAL AUTOMATION, BY END USER, 2023–2030 (USD MILLION)
TABLE 93
POST-ANALYTICAL AUTOMATION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 94
POST-ANALYTICAL AUTOMATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 95
POST-ANALYTICAL AUTOMATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 96
TOTAL LAB AUTOMATION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 97
LAB AUTOMATION MARKET FOR TOTAL LAB AUTOMATION, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 98
LAB AUTOMATION MARKET FOR TOTAL LAB AUTOMATION, BY END USER, 2023–2030 (USD MILLION)
TABLE 99
LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 100
LAB AUTOMATION SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 101
LAB AUTOMATION SOFTWARE MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 102
LAB AUTOMATION SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 103
LABORATORY INFORMATION MANAGEMENT SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 104
LABORATORY INFORMATION MANAGEMENT SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 105
LAB AUTOMATION MARKET FOR LABORATORY INFORMATION MANAGEMENT SYSTEMS, BY END USER, 2023–2030 (USD MILLION)
TABLE 106
ELECTRONIC LABORATORY NOTEBOOKS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 107
ELECTRONIC LABORATORY NOTEBOOKS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 108
ELECTRONIC LABORATORY NOTEBOOKS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 109
LABORATORY EXECUTION SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 110
LABORATORY EXECUTION SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 111
LABORATORY EXECUTION SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 112
SCIENTIFIC DATA MANAGEMENT SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
TABLE 113
SCIENTIFIC DATA MANAGEMENT SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 114
SCIENTIFIC DATA MANAGEMENT SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 115
ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 116
ROBOTIC SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 117
ROBOTIC SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 118
ROBOTIC SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 119
ROBOTIC ARMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 120
ROBOTIC ARMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 121
ROBOTIC ARMS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 122
TRACK ROBOTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 123
TRACK ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 124
TRACK ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 125
COLLABORATIVE ROBOTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 126
COLLABORATIVE ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 127
COLLABORATIVE ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 128
LAB MOBILE ROBOTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 129
MOBILE ROBOTS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 130
MOBILE ROBOTS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 131
AUTOMATED STORAGE & RETRIEVAL SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 132
AUTOMATED STORAGE & RETRIEVAL SYSTEMS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 133
AUTOMATED STORAGE & RETRIEVAL SYSTEMS MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 134
OTHER LAB AUTOMATION EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 135
OTHER LAB AUTOMATION EQUIPMENT MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 136
OTHER LAB AUTOMATION EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 137
LAB AUTOMATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 138
LAB AUTOMATION MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 139
LAB AUTOMATION MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 140
LAB AUTOMATION MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
TABLE 141
LAB AUTOMATION MARKET FOR ENVIRONMENTAL TESTING LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 142
LAB AUTOMATION MARKET FOR FORENSIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 143
LAB AUTOMATION MARKET FOR FOOD & BEVERAGE INDUSTRY, BY REGION, 2023–2030 (USD MILLION)
TABLE 144
LAB AUTOMATION MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
TABLE 145
LAB AUTOMATION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 146
NORTH AMERICA: LAB AUTOMATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 147
NORTH AMERICA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 148
NORTH AMERICA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 149
NORTH AMERICA: AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 150
NORTH AMERICA: AUTOMATED MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
NORTH AMERICA: MULTI-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 152
NORTH AMERICA: SINGLE-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153
NORTH AMERICA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
NORTH AMERICA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155
NORTH AMERICA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
NORTH AMERICA: LAB AUTOMATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 157
NORTH AMERICA: LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2023–2030 (USD MILLION)
TABLE 158
NORTH AMERICA: LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 159
NORTH AMERICA: LAB AUTOMATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 160
US: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 161
US: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
US: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163
US: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 164
US: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 165
CANADA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 166
CANADA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
CANADA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
CANADA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
CANADA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170
EUROPE: LAB AUTOMATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 171
EUROPE: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 172
EUROPE: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 173
EUROPE: AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174
EUROPE: AUTOMATED MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
EUROPE: MULTI-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
EUROPE: SINGLE-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177
EUROPE: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 178
EUROPE: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 179
EUROPE: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 180
EUROPE: LAB AUTOMATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 181
EUROPE: LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
EUROPE: LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
EUROPE: LAB AUTOMATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 184
GERMANY: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 185
GERMANY: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 186
GERMANY: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 187
GERMANY: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 188
GERMANY: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
FRANCE: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 190
FRANCE: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191
FRANCE: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
FRANCE: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 193
FRANCE: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
UK: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 195
UK: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196
UK: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197
UK: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
UK: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
ITALY: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 200
ITALY: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 201
ITALY: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 202
ITALY: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 203
ITALY: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
SWITZERLAND: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 205
SWITZERLAND: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
SWITZERLAND: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 207
SWITZERLAND: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 208
SWITZERLAND: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 209
NETHERLANDS: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 210
NETHERLANDS: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211
NETHERLANDS: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
NETHERLANDS: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
NETHERLANDS: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 214
REST OF EUROPE: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 215
REST OF EUROPE: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 216
REST OF EUROPE: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217
REST OF EUROPE: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
REST OF EUROPE: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
ASIA PACIFIC: LAB AUTOMATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 220
ASIA PACIFIC: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 221
ASIA PACIFIC: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222
ASIA PACIFIC: AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 223
ASIA PACIFIC: AUTOMATED MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 224
ASIA PACIFIC: MULTI-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 225
ASIA PACIFIC: SINGLE-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 226
ASIA PACIFIC: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227
ASIA PACIFIC: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 228
ASIA PACIFIC: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 229
ASIA PACIFIC: LAB AUTOMATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 230
ASIA PACIFIC: LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2023–2030 (USD MILLION)
TABLE 231
ASIA PACIFIC: LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 232
ASIA PACIFIC: LAB AUTOMATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 233
CHINA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 234
CHINA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 235
CHINA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 236
CHINA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 237
CHINA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 238
JAPAN: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 239
JAPAN: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
JAPAN: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 241
JAPAN: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 242
JAPAN: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 243
INDIA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 244
INDIA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 245
INDIA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 246
INDIA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 247
INDIA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 248
AUSTRALIA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 249
AUSTRALIA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
AUSTRALIA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 251
AUSTRALIA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 252
AUSTRALIA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 253
SOUTH KOREA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 254
SOUTH KOREA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 255
SOUTH KOREA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 256
SOUTH KOREA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 257
SOUTH KOREA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 258
REST OF ASIA PACIFIC: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 259
REST OF ASIA PACIFIC: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 260
REST OF ASIA PACIFIC: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 261
REST OF ASIA PACIFIC: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 262
REST OF ASIA PACIFIC: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 263
LATIN AMERICA: LAB AUTOMATION MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 264
LATIN AMERICA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 265
LATIN AMERICA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 266
LATIN AMERICA: AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 267
LATIN AMERICA: AUTOMATED MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 268
LATIN AMERICA: MULTI-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 269
LATIN AMERICA: SINGLE-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 270
LATIN AMERICA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 271
LATIN AMERICA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 272
LATIN AMERICA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 273
LATIN AMERICA: LAB AUTOMATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 274
LATIN AMERICA: LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2023–2030 (USD MILLION)
TABLE 275
LATIN AMERICA: LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 276
LATIN AMERICA: LAB AUTOMATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 277
BRAZIL: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 278
BRAZIL: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 279
BRAZIL: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 280
BRAZIL: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 281
BRAZIL: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 282
MEXICO: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 283
MEXICO: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 284
MEXICO: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 285
MEXICO: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 286
MEXICO: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 287
REST OF LATIN AMERICA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 288
REST OF LATIN AMERICA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 289
REST OF LATIN AMERICA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 290
REST OF LATIN AMERICA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 291
REST OF LATIN AMERICA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 292
MIDDLE EAST & AFRICA: LAB AUTOMATION MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 293
MIDDLE EAST & AFRICA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 294
MIDDLE EAST & AFRICA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 295
MIDDLE EAST & AFRICA: AUTOMATED LIQUID HANDLING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 296
MIDDLE EAST & AFRICA: AUTOMATED MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 297
MIDDLE EAST & AFRICA: MULTI-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 298
MIDDLE EAST & AFRICA: SINGLE-MODE MICROPLATE READERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 299
MIDDLE EAST & AFRICA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 300
MIDDLE EAST & AFRICA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 301
MIDDLE EAST & AFRICA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 302
MIDDLE EAST & AFRICA: LAB AUTOMATION MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 303
MIDDLE EAST & AFRICA: LAB AUTOMATION MARKET FOR DRUG DISCOVERY, BY TYPE, 2023–2030 (USD MILLION)
TABLE 304
MIDDLE EAST & AFRICA: LAB AUTOMATION MARKET FOR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 305
MIDDLE EAST & AFRICA: LAB AUTOMATION MARKET, BY END USER, 2023–2030 (USD MILLION)
TABLE 306
GCC COUNTRIES: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 307
GCC COUNTRIES: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 308
GCC COUNTRIES: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 309
GCC COUNTRIES: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 310
GCC COUNTRIES: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 311
REST OF MIDDLE EAST & AFRICA: LAB AUTOMATION MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
TABLE 312
REST OF MIDDLE EAST & AFRICA: AUTOMATED WORKSTATIONS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 313
REST OF MIDDLE EAST & AFRICA: OFF-THE-SHELF AUTOMATED WORK CELLS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 314
REST OF MIDDLE EAST & AFRICA: ROBOTIC SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 315
REST OF MIDDLE EAST & AFRICA: LAB AUTOMATION SOFTWARE MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 316
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LAB AUTOMATION MARKET
TABLE 317
LAB AUTOMATION MARKET: DEGREE OF COMPETITION
TABLE 318
LAB AUTOMATION MARKET: REGIONAL FOOTPRINT, 2024
TABLE 319
LAB AUTOMATION MARKET: PRODUCT FOOTPRINT, 2024
TABLE 320
LAB AUTOMATION MARKET: APPLICATION FOOTPRINT, 2024
TABLE 321
LAB AUTOMATION MARKET: END USER FOOTPRINT, 2024
TABLE 322
LAB AUTOMATION MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024
TABLE 323
LAB AUTOMATION MARKET: COMPETITIVE BENCHMARKING OF EMERGING PLAYERS/STARTUPS, BY PRODUCT
TABLE 324
LAB AUTOMATION MARKET: COMPETITIVE BENCHMARKING OF EMERGING PLAYERS/STARTUPS, BY REGION
TABLE 325
LAB AUTOMATION MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2026
TABLE 326
LAB AUTOMATION MARKET: DEALS, JANUARY 2021–APRIL 2026
TABLE 327
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 328
THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
TABLE 329
THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS
TABLE 330
THERMO FISHER SCIENTIFIC INC: DEALS, JANUARY 2021- APRIL 2026
TABLE 331
THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
TABLE 332
TECAN TRADING AG: COMPANY OVERVIEW
TABLE 333
TECAN TRADING AG: PRODUCTS OFFERED
TABLE 334
TECAN TRADING AG: PRODUCT LAUNCHES
TABLE 335
TECAN TRADING AG: DEALS
TABLE 336
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 337
DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 338
DANAHER CORPORATION: DEALS
TABLE 339
AGILENT TECHNOLOGIES: COMPANY OVERVIEW
TABLE 340
AGILENT TECHNOLOGIES: PRODUCTS OFFERED
TABLE 341
AGILENT TECHNOLOGIES: PRODUCT LAUNCHES AND APPROVALS
TABLE 342
AGILENT TECHNOLOGIES: DEALS
TABLE 343
AGILENT TECHNOLOGIES: EXPANSIONS
TABLE 344
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 345
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 346
F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES AND APPROVALS
TABLE 347
F. HOFFMANN-LA ROCHE LTD.: DEALS
TABLE 348
F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS
TABLE 349
METTLER TOLEDO: COMPANY OVERVIEW
TABLE 350
METTLER TOLEDO: PRODUCTS OFFERED
TABLE 351
METTLER TOLEDO: PRODUCT LAUNCHES AND APPROVALS
TABLE 352
METTLER TOLEDO: DEALS
TABLE 353
REVVITY INC.: COMPANY OVERVIEW
TABLE 354
REVVITY INC.: PRODUCTS OFFERED
TABLE 355
REVVITY, INC.: PRODUCT LAUNCHES AND APPROVALS
TABLE 356
REVVITY, INC.: DEALS
TABLE 357
EPPENDORF AG: COMPANY OVERVIEW
TABLE 358
EPPENDORF AG: PRODUCTS OFFERED
TABLE 359
EPPENDORF AG: PRODUCT LAUNCHES
TABLE 360
EPPENDORF AG: DEALS
TABLE 361
BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 362
BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 363
BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS
TABLE 364
BECTON, DICKINSON AND COMPANY: DEALS
TABLE 365
BECTON, DICKINSON AND COMPANY: EXPANSIONS
TABLE 366
WATERS CORPORATION: COMPANY OVERVIEW
TABLE 367
WATERS CORPORATION: PRODUCTS OFFERED
TABLE 368
WATERS CORPORATION: PRODUCT LAUNCHES AND APPROVALS
TABLE 369
WATERS CORPORATION: DEALS
TABLE 370
WATERS CORPORATION: EXPANSIONS
TABLE 371
SIEMENS HEALTHINEERS: COMPANY OVERVIEW
TABLE 372
SIEMENS HEALTHINEERS: PRODUCTS OFFERED
TABLE 373
SIEMENS HEALTHINEERS: PRODUCT LAUNCHES AND APPROVALS
TABLE 374
SIEMENS HEALTHINEERS: EXPANSIONS
TABLE 375
ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 376
ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 377
BIOMÉRIEUX: COMPANY OVERVIEW
TABLE 378
BIOMÉRIEUX: PRODUCTS OFFERED
TABLE 379
HAMILTON COMPANY: COMPANY OVERVIEW
TABLE 380
HAMILTON COMPANY: PRODUCTS OFFERED
TABLE 381
HAMILTON COMPANY: PRODUCT LAUNCHES AND APPROVALS
TABLE 382
HAMILTON COMPANY: DEALS
TABLE 383
HUDSON LAB AUTOMATION: COMPANY OVERVIEW
TABLE 384
HUDSON LAB AUTOMATION: PRODUCTS OFFERED
TABLE 385
HUDSON LAB AUTOMATION: DEALS
TABLE 386
GILSON, INC.: COMPANY OVERVIEW
TABLE 387
BMG LABTECH: COMPANY OVERVIEW
TABLE 388
FESTO AG & CO. KG: COMPANY OVERVIEW
TABLE 389
AURORA BIOMED INC.: COMPANY OVERVIEW
TABLE 390
HIGHRES BIOSOLUTIONS: COMPANY OVERVIEW
TABLE 391
OPENTRONS LABWORKS INC.: COMPANY OVERVIEW
TABLE 392
PEAK ANALYSIS AND AUTOMATION: COMPANY OVERVIEW
TABLE 393
QIAGEN N.V.: COMPANY OVERVIEW
TABLE 394
LABVANTAGE SOLUTIONS, INC: COMPANY OVERVIEW
TABLE 395
BIO-RAD LABORATORIES, INC: COMPANY OVERVIEW
TABLE 396
LABWARE: COMPANY OVERVIEW
TABLE 397
SYSMEX CORPORATION: COMPANY OVERVIEW
TABLE 398
UNIVERSAL ROBOTS: COMPANY OVERVIEW
TABLE 399
AB CONTROLS, INC.: COMPANY OVERVIEW
TABLE 400
AUTOMATA: COMPANY OVERVIEW
TABLE 401
SPT LABTECH: COMPANY OVERVIEW
TABLE 402
BIOSERO, INC.: COMPANY OVERVIEW
TABLE 403
METHODOLOGY-RELATED ASSUMPTIONS
TABLE 404
LIMITATIONS AND ASSOCIATED RISKS
FIGURE 1
LAB AUTOMATION MARKET SEGMENTATION
FIGURE 2
STUDY YEARS CONSIDERED
FIGURE 4
GLOBAL LAB AUTOMATION MARKET, 2024–2031 (USD MILLION)
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN LAB AUTOMATION MARKET, 2021–2026
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF LAB AUTOMATION MARKET
FIGURE 7
HIGH-GROWTH SEGMENTS IN LAB AUTOMATION MARKET, 2025
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN LAB AUTOMATION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 9
RISE IN DEMAND FOR HIGH-THROUGHPUT AND EFFICIENT TESTING TO DRIVE MARKET
FIGURE 10
NORTH AMERICA TO CONTINUE TO LEAD MARKET DESPITE HIGH ASIA PACIFIC CAGR
FIGURE 11
CHINA AND HOSPITALS LED RESPECTIVE SEGMENTS OF ASIA PACIFIC MARKET IN 2024
FIGURE 12
CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 13
LAB AUTOMATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14
LAB AUTOMATION MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15
LABORATORY AUTOMATION MARKET: VALUE CHAIN ANALYSIS
FIGURE 16
LAB AUTOMATION MARKET: ECOSYSTEM ANALYSIS
FIGURE 17
AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2023–2025 (USD)
FIGURE 18
AVERAGE SELLING PRICE OF ROBOTIC ARMS, BY KEY PLAYER, 2025 (USD THOUSAND)
FIGURE 19
IMPORT DATA FOR HS CODE 8479, BY COUNTRY, 2021–2025 (USD THOUSAND)
FIGURE 20
EXPORT DATA FOR HS CODE 8479, BY COUNTRY, 2021–2025 (USD THOUSAND)
FIGURE 21
TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS
FIGURE 22
INVESTMENT AND FUNDING SCENARIO, 2019–2023 (USD MILLION)
FIGURE 23
NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023
FIGURE 24
DEAL VALUE OF INVESTMENT, BY KEY PLAYER, 2019–2023 (USD MILLION)
FIGURE 25
MQTT’S CENTRAL ROLE IN COORDINATING COMMUNICATIONS BETWEEN DATA ACQUISITION MODULES AND USER INTERFACES
FIGURE 26
TRANSFORMING LABS WITH DIGITAL TWINS
FIGURE 27
PATENTS APPLIED AND GRANTED, 2016–2026
FIGURE 28
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
FIGURE 29
KEY BUYING CRITERIA FOR TOP FOUR END USERS
FIGURE 30
NORTH AMERICA: LAB AUTOMATION MARKET SNAPSHOT
FIGURE 31
ASIA PACIFIC: LAB AUTOMATION MARKET SNAPSHOT
FIGURE 32
REVENUE ANALYSIS OF KEY PLAYERS IN LAB AUTOMATION MARKET, 2021–2025 (USD BILLION)
FIGURE 33
MARKET SHARE ANALYSIS OF KEY PLAYERS IN LAB AUTOMATION MARKET, 2023
FIGURE 34
RANKING OF KEY PLAYERS IN LAB AUTOMATION MARKET, 2023
FIGURE 35
LAB AUTOMATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS)
FIGURE 36
LAB AUTOMATION MARKET: COMPANY FOOTPRINT, 2024
FIGURE 37
LAB AUTOMATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 38
EV/EBITDA OF KEY VENDORS, 2026
FIGURE 39
5-YEAR STOCK BETA OF KEY VENDORS, 2026
FIGURE 40
LAB AUTOMATION MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 41
THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT, 2025
FIGURE 42
TECAN TRADING AG: COMPANY SNAPSHOT, 2025
FIGURE 43
DANAHER CORPORATION: COMPANY SNAPSHOT, 2025
FIGURE 44
AGILENT TECHNOLOGIES: COMPANY SNAPSHOT, 2025
FIGURE 45
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT, 2025
FIGURE 46
METTLER TOLEDO: COMPANY SNAPSHOT, 2025
FIGURE 47
REVVITY, INC.: COMPANY SNAPSHOT, 2025
FIGURE 48
EPPENDORF AG: COMPANY SNAPSHOT, 2025
FIGURE 49
BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT, 2025
FIGURE 50
WATERS CORPORATION: COMPANY SNAPSHOT, 2025
FIGURE 51
SIEMENS HEALTHINEERS: COMPANY SNAPSHOT, 2025
FIGURE 52
ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2025
FIGURE 53
BIOMÉRIEUX: COMPANY SNAPSHOT, 2025
FIGURE 54
LAB AUTOMATION MARKET: RESEARCH DESIGN
FIGURE 55
KEY DATA FROM SECONDARY SOURCES
FIGURE 56
PRIMARY SOURCES
FIGURE 57
KEY INDUSTRY INSIGHTS
FIGURE 58
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 59
BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 60
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 61
LAB AUTOMATION MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
FIGURE 62
AUTOMATION MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 63
TOP-DOWN APPROACH
FIGURE 64
DATA TRIANGULATION
Methodology
Four primary studies have been undertaken to size the lab automation market. Secondary research has been used to obtain preliminary data for the lab automation market and peer and parent markets. Data were collected from 3–5 secondary sources and validated by primary sources for assumptions and market sizing. Through top-down and bottom-up approaches, the overall market size was informed and further broken down, and data was triangulated for segment and subsegment sizing.
Secondary Research
These included directories, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings, and investor presentations, among others. Through these sources, one can gain critical data about market leaders, how the industry is divided into sectors, and how technology varies from one industry level to another within lab automation.
Primary Research
Primary research consisted of interviews with supply- and demand-side stakeholders to obtain quantitative and qualitative insights. On the demand side, primary sources involved in the study included physicians, researchers, department heads, staff from diagnostic centers, hospital staff, and those attached to the research institutes, while on the supply side, it involved CEOs, area sales managers, territory and regional sales managers, and various other top executives of relevant companies. These direct meetings with people in key leadership positions helped validate assumptions arising from secondary research and bring them face-to-face so that any assumptions could also be directly questioned.
Note 1: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 1 billion, Tier 2 = <USD 500 million, and Tier 3 = <USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This report used revenue-share analyses of major companies to determine the size of the global lab automation market. This was accomplished by identifying the major market participants and calculating their lab automation revenue using information gathered during the primary and secondary research stages. Examining the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, primary research involved in-depth interviews with important thought leaders, including directors, CEOs, and important marketing executives.
Segmental revenues were computed using the revenue mapping of the leading solution/service providers to determine the worldwide market value. The following steps were engaged in this process
- Making a list of the leading international companies in the lab automation industry
- Charting the annual profits made by the leading companies in the lab automation sector (or the closest stated business unit/product category)
- As of 2025, revenue mapping of leading companies to cover a significant portion of the global market
- Calculating the lab automation industry's global value
Data Triangulation
The above process has divided the lab automation market into several segments and subsegments. Then, data triangulation and the market segmentation process are conducted to confirm the accuracy of the data for each segment. Both factors and trends from the demand and supply sides were researched. Top-down and bottom-up approaches yield the outcome from the analysis of the Lab Automation market.
Market Definition
The lab automation market includes automated workstations, off-the-shelf automated work cells, robotics, automated storage & retrieval systems, and software that automates laboratory procedures to boost efficiency, productivity, and accuracy. It is integrated with devices to aid in complex operations, data collection, and repetitive procedures across life sciences, academic institutes, diagnostics, pharmaceutical research, and other labs. Drug discovery, diagnostics, proteomics, genomics, and microbiology are some of the most critical applications of lab automation solutions.
Key Stakeholders
- Lab automation solution manufacturers, suppliers, and providers
- Lab automation equipment and software solution providers
- Lab automation integrated solution providers
- Academic institutions and private research institutions
- Environmental testing laboratories
- Food & beverage testing centers
- Hospitals and diagnostic centers
- Forensic laboratories
- CROs and CDMOs
- Pharmaceutical & biopharmaceutical companies
- Consulting firms
Report Objectives
-
To define, describe, and forecast the lab automation market based on product, application,
end user, and region - To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the revenue of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their market ranking and core competencies
- To benchmark players within the market using a proprietary competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of business strategy excellence and strength of product portfolio
- To track and analyze competitive developments such as product launches, agreements, expansions, collaborations, and acquisitions in the lab automation market
Available customizations:
-
Using market data, MarketsandMarkets offers customization according to the company's requirements. Here are the available customization options for the global Lab Automation market
Product Analysis
Company Information
Geographic Analysis
-
Product matrix that provides a comparison of product portfolios of the top 5 companies.
- In-depth profiling of additional market players (up to 5)
- Further breakdown of the Rest of Europe lab automation market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others.
- Further breakdown of the Rest of Asia Pacific lab automation market into Singapore, Taiwan, New Zealand, the Philippines, Malaysia, and other APAC countries.
- Further breakdown of the Rest of Latin America lab automation market into Argentina, Chile, Colombia, and others.
-
Product matrix that provides a comparison of product portfolios of the top 5 companies.
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Lab Automation Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Previous Next
